CardioNet posts strong Q1 profits
CardioNet, a wireless medical technology company with a focus on the diagnosis and monitoring of cardiac arrhythmias, has reported positive results for the first quarter, which ended March 31.
The company said that revenues for the first quarter of 2008 increased to $25.5 million compared to $11.1 million in the first quarter of 2007, an increase of 129.4 percent. After taking into account the acquisition of PDSHeart, adjusted revenue was $15.2 million for first quarter 2007, an increase of $10.3 million, or 67.9 percent.
On a GAAP basis, net income for the first quarter of 2008 increased to $200,000 compared to a net loss of $3.2 million for the same period last year, according to San Diego.-based company. Adjusted net income for the first quarter of 2008 increased to $400,000, excluding the impact of integration and restructuring costs, compared to a net loss of $3.2 million, for the same period last year, CardioNet said.
“In the first quarter of 2008, CardioNet invested heavily in sales and marketing, additional management talent, research and development and other operating expenses that will help drive our future growth. As our revenue continues to grow over the balance of 2008, we will be able to leverage these expenses over a larger revenue base,” said Marty Galvan, CardioNet’s chief financial officer.
The company said that revenues for the first quarter of 2008 increased to $25.5 million compared to $11.1 million in the first quarter of 2007, an increase of 129.4 percent. After taking into account the acquisition of PDSHeart, adjusted revenue was $15.2 million for first quarter 2007, an increase of $10.3 million, or 67.9 percent.
On a GAAP basis, net income for the first quarter of 2008 increased to $200,000 compared to a net loss of $3.2 million for the same period last year, according to San Diego.-based company. Adjusted net income for the first quarter of 2008 increased to $400,000, excluding the impact of integration and restructuring costs, compared to a net loss of $3.2 million, for the same period last year, CardioNet said.
“In the first quarter of 2008, CardioNet invested heavily in sales and marketing, additional management talent, research and development and other operating expenses that will help drive our future growth. As our revenue continues to grow over the balance of 2008, we will be able to leverage these expenses over a larger revenue base,” said Marty Galvan, CardioNet’s chief financial officer.